CELU vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Captures Institutional Edge (2โ2 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while CELU counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, CELU trades at N/M Forward P/E with -254.0% operating margin (-5.3% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CELU Revenue | ENSC Revenue | CELU Op. Margin | ENSC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $10M | $0M | -1064.0% | -41.0% | ENSC |
| FY2021 | $20M | $0M | -511.2% | -562.7% | CELU |
| FY2022 | $20M | $0M | -142.4% | -959.9% | CELU |
| FY2023 | $20M | $0M | -844.4% | -480.5% | ENSC |
| FY2024 | $50M | $10M | -70.7% | -129.2% | CELU |
| FY2025 | $30M | $10M | -230.9% | -202.1% | ENSC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CELU | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.2M | $7.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | -5.3% | -15.1% | Higher Growth | CELU |
| Operating Margin (TTM) Profitability | -254.0% | -281.3% | Higher Margin | CELU |
| Net Profit Margin Profitability | -245.7% | -280.5% | Higher Margin | CELU |
| Return on Equity (ROE) Capital Efficiency | -6367.2% | -1295.1% | Higher ROE | ENSC |
| 52-Week Range Position Momentum | 2% ($0โ$3) | 8% ($0โ$2) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 2.01ฮฒ ยท 135% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |